Pfizer says vaccine trial data for the under 5s will include results from booster shots; Italy tightens its vaccination rules as it reports a record rise in cases
- Novak Djokovic’s Australian Open hopes dashed after visa cancelled at airport
- Ministers must act now on NHS staffing crisis, health chiefs warn
- Grammy awards 2022 postponed indefinitely due to Omicron
- Covid ‘vaccination doubt line’ receiving up to 1,000 calls a day in Netherlands
Pfizer Inc expects the latest results from a clinical trial for kids under the age of five of the Covid-19 vaccine it developed with Germany’s BioNTech SE by April, a top company scientist has said according to Reuters.
“The study has been amended to give a third dose to everybody who’s less than five at least eight weeks after their last vaccination,” Dr Alejandra Gurtman, a Pfizer vaccine researcher said at a meeting of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP).
